Thalidomide vs argon plasma coagulation for stomach bleeding in cirrhosis
Treatments studied
Part of Digestive system, Heart & circulation clinical trials.
This trial compares two treatments for anemia caused by GAVE, a condition with bleeding stomach blood vessels. It tests a medication (thalidomide) against a procedure (argon plasma coagulation) to see which is better at improving anemia in people with cirrhosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with cirrhosis (liver scarring).
- You have GAVE (abnormal blood vessels in the stomach) that is causing iron-deficiency anemia.
- You are not bleeding from another cause in your stomach.
- You are not pregnant or of childbearing age, and you do not have severe kidney, heart, or nerve problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a pill (dabigatran) or a daily injection (enoxaparin) is better at preventing new blood clots in the liver vein for people with cirrhosis. Both are blood thinners, and the study wants to see which one is safer and more effective.
This study compares two procedures to treat bleeding from enlarged veins in the esophagus or stomach for people with cirrhosis and an overactive spleen. The goal is to see which approach reduces bleeding risk and improves blood counts over time.
This trial compares two medicines, terlipressin and somatostatin, to see which one better controls bleeding from enlarged veins in the esophagus or stomach in people with cirrhosis and kidney problems. The goal is to find a safer and more effective treatment for this serious condition.
This trial tests whether combining thalidomide and glutamine helps people with bleeding caused by past radiation treatment to the abdomen or pelvis. The medication may reduce inflammation and help healing.
This trial tests a treatment called endoscopic radiofrequency, which uses heat to stop bleeding from abnormal blood vessels in the stomach (a condition called GAVE). It aims to reduce the need for blood transfusions and improve anemia.
This trial tests if giving tranexamic acid and vitamin K by injection can help control bleeding from the upper digestive tract in people with liver cirrhosis. It may offer a way to stop bleeding more quickly.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.